CONTINUE TO SITE ➞

Don't miss tomorrow's biopharma industry news

Let BioPharma Dive's free newsletter keep you informed, straight from your inbox.

Daily Dive M-F

Commercialization Weekly Every Wednesday

Gene Therapy Weekly Every Thursday

Emerging Biotech Weekly Every Tuesday

By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Deep Dive
Library
Events
Press Releases

Pharma
Biotech
FDA
Clinical Trials
Deals
Drug Pricing
Gene Therapy

What We're Reading: Page 48

Industry reads hand-picked by our editors

Aug 14, 2024

Financial Times
AstraZeneca hits £200bn valuation
FirstWord Pharma
Rivus touts mid-stage win for muscle-preserving obesity candidate
C&EN
Will single-molecule protein sequencing be the next generation of proteomics?
Nature
Five ways science is tackling the antibiotic resistance crisis

Aug 13, 2024

Axios
Weight-loss drugs hit health care real estate
Fierce Pharma
Judge denies Novartis’ bid to block generic Entresto launch
Reuters
Biden targets tumors with $150 mln funding for ‘Cancer Moonshot’ program
Financial Times
NHS launches ‘subscription’ scheme for antibiotics with pharma sector

Aug 12, 2024

Reuters
US FDA extends review of Humacyte’s blood vessel implant
ApexOnco
Fresh questions over DLL3
AP News
FDA approves first nasal spray to treat dangerous allergic reactions
Fierce Biotech
Gilead pays J&J $320M to exit licensing deal for seladelpar

Aug 09, 2024

The 19th
IUD insertion is painful. For the first time, the CDC issued guidance for physicians.
Science
Bold new strategy to suppress HIV passes first
Bloomberg
23andMe’s Quarterly Sales Miss Estimates as CEO Seeks Control

Aug 08, 2024

MIT Technology Review
How covid conspiracy theories led to an alarming resurgence in AIDS denialism
Fierce Biotech
Lilly faces Phase 2 failure of tau-targeting med
FirstWord Pharma
BMS under FDA fire for misleading efficacy claims on Krazati website
Bloomberg
What Happens When Ozempic Takes Over Your Town

Aug 07, 2024

Financial Times
Roche considers options for $1.9bn cancer data start-up
Bloomberg
Novo Owner Bets Gene Analysis Firm Can Help Make Cancer Vaccines
ApexOnco
Blood cancer gene therapies enter the clinic

Aug 06, 2024

C&EN
Sickle cell disease in India: The quest for a cure
Stat
‘Jerking families around’: Canceled Roche rare disease trial devastates parents, angers researchers
FirstWord Pharma
New Jersey site bears brunt of further BMS layoffs

Previous Next

Get the free newsletter

Subscribe to BioPharma Dive for top news, trends & analysis

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.

Library resources

Survey Report
The Evolution of Outsourced Buffer Production in Manufacturing Custom content for Thermo Fisher Scientific
Playbook
How to Unlock A Successful ICH E6(R3) Implementation Custom content for WCG
Playbook
Successful Biomarker-Driven Cancer Drug Development Custom content for Labcorp

View all

Company Announcements

View all | Post a press release

Events

View all | Promote an event

Industry Intel

Enhance Drug Discovery with CADD and Agentic AI on Rescale, AWS, and NVIDIA Webinar - on demand • Provided by Amazon Web Services (AWS), NVIDIA, and Rescale
AI-Powered Biomarker Discovery: From Screening to Translational Insights Webinar - on demand • Provided by Danaher
Revolutionizing Next Generation Gene Therapies with On-Demand Large DNA Construct Synthesis and Novel, Designable Delivery Vehicles Webinar - on demand • Provided by Ansa Biotechnologies

Explore

About
Editorial Team
Contact Us
Newsletter
Purchase Licensing Rights
Press Releases
What We're Reading

Reach our audience

Advertising
Post a press release
Promote an event

Related Publications

Healthcare Dive
MedTech Dive

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Home
- Pharma
- Biotech
- FDA
- Clinical Trials
- Deals
- Drug Pricing
- Gene Therapy
Deep Dive
Library
Events
Press Releases

Get BioPharma Dive in your inbox

The free newsletter covering the top industry headlines

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.